Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Ambroxol hydrochloride 3 mg/mL and guaifenesin 10 mg/mL and terbutaline sulfate 250 microgram/mL oral solution |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Guaifenesin |
Inferred relationship |
Some |
3 |
Ambroxol hydrochloride 3 mg/mL and guaifenesin 10 mg/mL and terbutaline sulfate 250 microgram/mL oral solution |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Guaifenesin |
Inferred relationship |
Some |
3 |
Ambroxol- and guaifenesin- and terbutaline-containing product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Guaifenesin |
Inferred relationship |
Some |
3 |
Product containing only ambroxol and guaifenesin and terbutaline (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Guaifenesin |
Inferred relationship |
Some |
3 |
Product containing ambroxol and guaifenesin and terbutaline in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Guaifenesin |
Inferred relationship |
Some |
3 |
Ambroxol and guaifenesin and terbutaline only product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Guaifenesin |
Inferred relationship |
Some |
3 |
Caffeine 25 mg and guaifenesin 100 mg and paracetamol 500 mg oral capsule |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Guaifenesin |
Inferred relationship |
Some |
3 |
Caffeine 25 mg and guaifenesin 100 mg and paracetamol 500 mg oral capsule |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Guaifenesin |
Inferred relationship |
Some |
3 |
Caffeine- and guaifenesin- and paracetamol-containing product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Guaifenesin |
Inferred relationship |
Some |
3 |
Caffeine and guaifenesin and paracetamol only product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Guaifenesin |
Inferred relationship |
Some |
3 |
Product containing precisely guaifenesin 100 milligram and paracetamol 500 milligram and phenylephrine (as phenylephrine hydrochloride) 5 milligram/1 each conventional release oral capsule (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Guaifenesin |
Inferred relationship |
Some |
3 |
Product containing precisely guaifenesin 100 milligram and paracetamol 500 milligram and phenylephrine (as phenylephrine hydrochloride) 5 milligram/1 each conventional release oral capsule (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Guaifenesin |
Inferred relationship |
Some |
3 |
Product containing guaifenesin and paracetamol and phenylephrine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Guaifenesin |
Inferred relationship |
Some |
3 |
Guaifenesin and paracetamol and phenylephrine only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Guaifenesin |
Inferred relationship |
Some |
3 |
Guaifenesin and paracetamol and phenylephrine only product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Guaifenesin |
Inferred relationship |
Some |
3 |
Guaifenesin- and paracetamol- and phenylephrine-containing product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Guaifenesin |
Inferred relationship |
Some |
3 |
Product containing precisely guaifenesin 20 milligram/1 milliliter and pseudoephedrine hydrochloride 6 milligram/1 milliliter conventional release oral solution (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Guaifenesin |
Inferred relationship |
Some |
2 |
Product containing precisely guaifenesin 20 milligram/1 milliliter and pseudoephedrine hydrochloride 6 milligram/1 milliliter conventional release oral solution (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Guaifenesin |
Inferred relationship |
Some |
2 |
Product containing precisely guaifenesin 20 milligram/1 milliliter and levomenthol 220 microgram/1 milliliter conventional release oral solution (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Guaifenesin |
Inferred relationship |
Some |
2 |
Product containing precisely guaifenesin 20 milligram/1 milliliter and levomenthol 220 microgram/1 milliliter conventional release oral solution (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Guaifenesin |
Inferred relationship |
Some |
2 |
Product containing guaifenesin and levomenthol (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Guaifenesin |
Inferred relationship |
Some |
2 |
Guaifenesin- and levomenthol-containing product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Guaifenesin |
Inferred relationship |
Some |
2 |
Guaifenesin and levomenthol only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Guaifenesin |
Inferred relationship |
Some |
2 |
Guaifenesin and levomenthol only product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Guaifenesin |
Inferred relationship |
Some |
2 |
Product containing caffeine and guaifenesin and paracetamol (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Guaifenesin |
Inferred relationship |
Some |
3 |
Product containing only caffeine and guaifenesin and paracetamol (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Guaifenesin |
Inferred relationship |
Some |
3 |